Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Amarantus Bioscience Holdi AMBS
Posted On: 08/08/2016 5:39:03 PM
Post# of 30071
Posted By: All Aboard
I understand that management gets to continue to receive a salary. But the Series C preferred is a great example of how hard they have been hit by their own utter incompetence.

On April 1, 2013, the company created the Series C preferred stock in order to issue 750,000 shares of Amarantus to officers and directors. Each share converted 1:1 into a total of 750,000 shares of common.

At the time, those shares were worth $60,000.

After the first split, those 750,000 shares convert into 5,000 shares of common.

After the next split (which - at best - will be a 1:5), the Series C will convert into 1,000 shares of common.

Gerald Commissiong gets 466.66 shares;
John Commissiong gets 266.66 shares; and
Marc Faeber gets 266.66 shares.

Currently worth a total of $225.

WOW. It is almost comical if it wasn't so devastating to all.















(5)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site